Steven A. Everett, Mba., Ph.D. Email and Phone Number
Steven A. Everett, Mba., Ph.D. work email
- Valid
Steven A. Everett, Mba., Ph.D. personal email
Steven A. Everett, Mba., Ph.D. phone numbers
Senior executive with multidisciplinary skills in drug discovery and early stage drug development. Proven track record of utilizing cutting edge academic research, novel drug discovery paradigms, and translational science to progress groundbreaking drug treatment options to patients suffering from cancer. Skills: Drug discovery | Drug development | Cell & tumor biology | Biochemistry | Enzymology | Biotechnology | Translational biology & medicine | DMPK & biomarkers | Tumor biology & models | In vivo | Medicinal chemistry | Drug design | Target identification & validation | HTS | Computational chemistry | Structural biology | Drug metabolism | Pharmacology | Safety Toxicity | Directing CROs | IND | Leadership | Management | Cross-functional teams | Strategy | Communication | Planning | Budgets | Entrepreneurship | Intellectual property | Patent strategy | Start-ups | Cancer | Oncology | Financing | Pharma partnership & co-development deals Specialities: Rational 'mechanism-led' drug design, drug conjugate chemistries, biological proof-of-concept, rapid & capital efficient achievement of value inflexion milestones in the drug discovery & development pathway.
Maverix Oncology, Inc.
View- Website:
- maverixoncology.com
- Employees:
- 3
-
Founder, President And CeoMaverix Oncology, Inc.Palo Alto, Ca, Us -
Founder, President & CeoMaverix Oncology, Inc. May 2014 - PresentPalo Alto, California, UsMaveriX is a globally orientated biotechnology company focused on the discovery, development, and commercialization of targeted small molecule cancer chemo-immunotherapies. Our technology approach leverages unexploited insights into cancer and immune cell metabolism within the tumor microenvironment which are common to all cancers. Our novel platform is designed to selectively deliver the tumor cell killing benefits of chemotherapy while stimulating a robust immune response to attack a wide range of cancers. Our experienced team is developing a proprietary pipeline of drug candidates with the goal of bringing new and improved treatments to patients suffering from cancer. For more information about the company visit the website https://www.maverixoncology.com/ -
Adjunct FacultyUcsf | Pharmaceutical Chemistry Jun 2010 - Jan 2014San Francisco, California, UsThe University of California, San Francisco is widely regarded as one of the world's leading universities in the health sciences. The Department of Pharmaceutical Chemistry is part of the School of Pharmacy ranked first in the nation for its Doctor of Pharmacy Program. -
Founding Director | Chief Scientific OfficerCyterix Pharmaceuticals Apr 2010 - Jul 2013A privately held cancer therapeutics company committed to the discovery and development of novel prodrugs designed to exhibit superior safety and activity over traditional cancer chemotherapy.
-
Founding Director | President & CeoCyterix Pharmaceuticals Apr 2010 - Jun 2013
-
Entrepreneur-In-Residence | Scientific AdvisorThreshold Pharmaceuticals Jun 2008 - Oct 2010A late clinical stage biopharmaceutical company focused on identifying and advancing of cancer therapeutics by targeting hypoxia present in most solid tumors and some hematologic malignancies.
-
Head Of Group | Drug Discovery & Translational ResearchUniversity Of Dundee | Cancer Research Uk Nov 2005 - Jun 2009Dundee, Angus, GbThe University of Dundee is internationally recognized for its excellence in life sciences and medical research with particular expertise in cancer, diabetes, cardiovascular disease. The University has a top-rated medical school with research expanding from 'the cell to the clinic to the community', while the College of Life Sciences is home to some of the world’s most cited scientists.Cancer Research UK is the world's largest independent cancer research charity with the aim of reducing the number of deaths from cancer. -
Founding Director | Head Of Discovery Research | Scientific AdvisorSpear Therapeutics | Cancer Research Technology Sep 2003 - Apr 2009Spear is a start-up company focusing on the discovery and development of small molecule drugs for the treatment of cancer. The company has proprietary expertise in the design of prodrugs selectively activated by enzymes over-expressed in a broad range of primary and metastatic cancers to a high frequency.
-
Principal Investigator | Scientist | Senior ScientistUniversity Of Oxford | Gray Institute | Cancer Research Uk Nov 1992 - Sep 2005Oxford, Oxfordshire, GbRecognized as a global center of excellence in radiation biology and oncology, the Gray Institute is a multi-disciplinary research environment that holds a reputation for strong translational biology and excellent clinical links in one of the world’s leading universities. -
Postdoctoral ResearcherHahn-Meitner Institute | Association For International Cancer Research Jun 1991 - Oct 1992The Hahn-Meitner Institute for Nuclear Research was named after the physicists and Nobel Prize winners Otto Hahn and Lisa Meitner who worked on radioactivity and nuclear physics and discovered nuclear fission and is a world leader in radiation science.The Association for International Cancer Research is an independent charity whose aim is to support the fundamental research by eminent and promising scientists throughout the world, into the causes and prevention of cancer.
Steven A. Everett, Mba., Ph.D. Skills
Steven A. Everett, Mba., Ph.D. Education Details
-
Ulster UniversityPhysical Chemistry | Biology -
Brunel University Of LondonInternational Business -
Buckinghamshire New UniversityGeneral -
Technische Universität BerlinRadiation Chemistry | Biology -
Ulster UniversityChemistry | Biology
Frequently Asked Questions about Steven A. Everett, Mba., Ph.D.
What company does Steven A. Everett, Mba., Ph.D. work for?
Steven A. Everett, Mba., Ph.D. works for Maverix Oncology, Inc.
What is Steven A. Everett, Mba., Ph.D.'s role at the current company?
Steven A. Everett, Mba., Ph.D.'s current role is Founder, President and CEO.
What is Steven A. Everett, Mba., Ph.D.'s email address?
Steven A. Everett, Mba., Ph.D.'s email address is st****@****ogy.com
What is Steven A. Everett, Mba., Ph.D.'s direct phone number?
Steven A. Everett, Mba., Ph.D.'s direct phone number is +165086*****
What schools did Steven A. Everett, Mba., Ph.D. attend?
Steven A. Everett, Mba., Ph.D. attended Ulster University, Brunel University Of London, Buckinghamshire New University, Technische Universität Berlin, Ulster University.
What skills is Steven A. Everett, Mba., Ph.D. known for?
Steven A. Everett, Mba., Ph.D. has skills like Drug Discovery, Biotechnology, Life Sciences, Drug Development, Medicinal Chemistry, Oncology, Pharmaceutical Industry, Strategy, Entrepreneurship, Biomarkers, Research, Technology Transfer.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial